IndustryNet - The Industrial Marketplace
      

Actinium Pharmaceuticals, Inc.

Actinium Pharmaceuticals, Inc.

Actinium Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with cancer. The company is particularly known for its lead product, Iomab-B, which is currently being evaluated in the Phase 3 SIERRA clinical trial. Actinium utilizes its proprietary AWE Technology, which leverages Actinium-225, a radioisotope, to create targeted therapies aimed at improving treatment outcomes for patients. The company is committed to advancing its product pipeline and exploring new therapeutic options in the oncology space.

Looking for business intelligence data on Actinium Pharmaceuticals or other suppliers of Pharmaceuticals? Set up your free account with IndustrySelect.
Location Information
Physical Address:
275 M... (click to view)
New York, NY 10016
Mailing Address:
100 P... (click to view)
New York, NY 10017-5541
Contact Information
Phone:
646-677-XXXX (click to view)
Product & Service Information
Capabilities:

PHARMACEUTICALS

Map & Driving Directions
View Map of Actinium Pharmaceuticals, Inc. in New York, NY 10016
Driving directions from:  
Supplier Notes
 
✓ Free Quotes & Info
Actinium Pharmaceuticals, Inc. is not yet set up to receive email, but you can get FREE quotes & information from other preferred/featured suppliers of Pharmaceuticals below*





*This form will not be sent to Actinium Pharmaceuticals, Inc. To contact Actinium Pharmaceuticals, Inc. please call the number listed to the left.
Is this your business? Claim this listing for FREE to update your info, logo, & more! [Video]

Get found! Upgrade your listing to move up in the search results and receive buyer inquiries.
   
A service of MNI